Recent articles [1] [2] [3] [4] [5] [6] [7] in Progress in Transplantation have outlined treatment issues during care of adult brain dead organ donors prior to organ removal. In general, it has been assumed that maintaining hemodynamic variables and laboratory parameters within normal ranges is the preferred goal. Although acceptance of organs from donors with deviations from normative values has been possible, none of those deviations appear to enhance organ function. Therefore, the guidelines proposed herein focus on normative hemodynamic values and laboratory parameters as therapeutic goals.
Continuing care for the donor is often complex and extends over several hours. It is recommended that the organ procurement coordinator (OPC) create a prioritized problem list as care is initiated. Items may then be deleted as problems resolve or added as new issues emerge during subsequent care. A sample flowsheet is also included below.
It is recognized that portions of these guidelines may differ from established treatment protocols from individual organ procurement organizations (OPOs). In such cases, our guidelines, based upon our experiences in donor care and standard critical care practice, are offered for consideration. Final treatment objectives and methods should be determined by local OPOs. Finally, most guidelines reach an end point when consultation between the organ procurement coordinator and a physician is recommended. This physician may be an OPO medical liaison or hospital-assigned physician, but such a physician resource must be available for discussion.
Rx Guideline -Standard Donor Care
Introduction: As the procurement coordinator assumes responsibility for continuing donor care, priorities for assessment and treatment change to assure that the best physiological support will be given to maximize the potential for successful organ transplantation. That transition is facilitated by policies that allow ongoing care orders be written by the coordinator and supported by the OPO's medical staff. Some prior treatment may no longer be appropriate for organ procurement, but many aspects of fundamental patient care should be continued.
The coordinator should write orders to initiate standard donor care: The above order set provides a "safety net" of call orders so that the coordinator is alerted to significant changes in donor status. It also prescribes the foundation for ongoing monitoring of physiological and laboratory variables. Donor care is subsequently directed and "fine-tuned" through the Rx Guidelines that follow. These include treatment plans for hypertension, hypotension, glucose management, temperature, anemia, coagulopathy and thrombocytopenia, mechanical ventilation, fluid and electrolyte treatment, polyuria, and acid-base changes. Each may be referenced as that circumstance/problem arises. Although the guidelines are not intended to compartmentalize the complex process of overall donor care, they may be helpful in providing useful resources in methods of treatment, precautions, and points at which MD consultation is appropriate.
Rx Guideline -Hypertension
Introduction: It is unusual for hypertension to occur after brain death, although it is common during the evolution of brain death. Because donor organs are likely at more risk from hypotension than hypertension, a conservative treatment plan is recommended. The goal for mean arterial blood pressure (MAP) is <90 mm Hg when the donor is hypertensive, but always above 65-70 mm Hg. The MAP is measured via an intraarterial catheter, non-invasive blood pressure device or calculated by: diastolic pressure + 1/3(systolic -diastolic pressures) + 5. Therapy should be started if the MAP is sustained above 95 mm Hg for 30 minutes after certification of brain death. Placement of the arterial catheter in an upper extremity is preferred.
Treatment:
A. Reduce or discontinue inotropic or vasopressor medications or infusions. B. If the difference between the MAP recorded via an arterial catheter and noninvasive machine is > 20 mmHg -discuss which blood pressure to follow with the physician consultant (MD). Differences in mearsurements taken from an automatic oscillometric non-invasive device and an arterial catheter may be due to several technical factors. 8, 9 C. Give labetalol 20 mgm IV bolus every 20 minutes until MAP goal (65-70 mm Hg) is reached. If the MAP goal is not achieved after 2 doses begin: D. Nicardipine IV infusion -start infusion at 5mgm/hr and titrate up to 15 mgm/hr to achieve the MAP goal. E. If the MAP goal is not achieved after titration of nicardipine to 15 mgm/hr, consult MD.
Rx Guideline -Hypotension
Introduction: Hypotension commonly follows brain death and may be caused by on-going or pre-existing conditions leading to hemorrhagic, cardiogenic, distributive, or obstructive types of "shock". In the absence of these pre-existing conditions causing shock, hypotension commonly occurs after brain death due to loss of vasomotor centers in the brain causing vasodilation, decreased contractility of the heart, or hypovolemia due to ongoing fluid loss due to diabetes insipidus. Hypotension will be defined as a mean arterial blood pressure (MAP) of < 60mmHg as measured from an indwelling arterial catheter, non-invasive blood pressure machine, or calculated by: diastolic pressure + 1/3 [systolic -diastolic pressure] + 5. Placement of an arterial line for monitoring is desirable, and insertion in an upper extremity is preferred. The treatment goal for MAP is 65-75mmHg.
I. Assessment:
A. 
Rx Guideline -Coagulopathy and Thrombocytopenia
Introduction: Blood loss from any cause may endanger continued perfusion to donor organs. Disseminated intravascular coagulation or a "dilutional" coagulopathy may occur after severe trauma and resuscitation. The treatment goal is to correct clinically important coagulopathy and thrombocytopenia. Because ongoing hemorrhage may worsen coagulation abnormalities and/or thrombocytopenia, refer to Rx GuidelineAnemia, and correct disorders noted. It is recognized that commonly performed laboratory tests of coagulation, i.e. partial thromboplastin time (PTT), prothrombin time (PT), fibrinogen, and the platelet count may be abnormal but treatment may not be required. Treatment is reserved for donors who appear to have continuing significant blood loss evidenced by physical assessment, hemodynamic instability and changes in coagulation parameters.
I. Assessment
II. Treatment of continued signs of significant blood loss and associated abnormal coagulation results or platelet count:
A. Consult MD for external bleeding or further assessment of possible GI or urinary injury. Treat anemia as per Rx Guideline -Anemia. B. Platelets-Platelet dysfunction due to prior aspirin intake can be overcome by infusing a platelet 5-pack dose even though the platelet count is normal. Discuss with MD. Otherwise, treat for platelet count < 65,000/cc 
Rx Guideline -Mechanical Ventilation
Introduction: Under most circumstances volume limited controlled mechanical ventilation will be used during donor care. Pressure limited controlled mechanical ventilation is indicated when peak and plateau airway pressures are elevated, indicating high airway resistance or poor lung compliance (see below 
II. General Ventilator Settings

III. General Respiratory Treatments
A. Assure adequate suctioning of excessive sputum. B. Assure bronchodilators are ordered as indicated by wheezing or a peak airway pressureplateau airway pressure gradient of > 10 cm H 2 O. C. Other forms of chest physiotherapy or related devices are optional but should be considered.
IV. Ventilator Adjustments -Volume-limited controlled ventilation
Note: Repeat ABG's 30 minutes after any change of ventilator settings to assess effects Note: Combinations of adjustments listed below may be necessary as guided by arterial blood gas results and airway pressures. A. Acidemic pH -arterial pH < 7.35
Rx Guideline -Fluid Electrolyte Treatment
Introduction: The treatment goal is to maintain electrolytes within the normal limits established by the clinical laboratory in each hospital. To achieve that goal, laboratory testing of Sodium (Na), Potassium (K), Chloride (Cl), Bicarbonate (HCO 3 ), Magnesium (Mg), Phosphorous (P), and ionized Ca (Ca ++ ), should be completed every 4 hours. More frequent testing may be needed to monitor/ treat critical levels. Any testing should be delayed for 30 minutes after the last dose of the electrolyte being treated. All electrolyte replacement should be by the intravenous route.
I. General Table of Normal Values:
Na 136 If hyperglycemia is present, the serum Na may be low because of the high blood glucose. If blood sugar > 300, a "corrected" serum Na may be calculated by adding to the measured Na -1.6 meq for each 100 gm/dl of blood glucose above 100. See Rx Guideline -Hyperglycemia and treat. c. If Na < 128 mEq/L give 3% NaCl per infusion (central line preferred) at 40 cc/hr X 3 hours. d. If Na remains < 133 mEq//hr after 3% NaCl infusion, consult MD.
B. Potassium (K) 1. Hyperkalemia -treat serum K ≥ 5.8 mEq/L a. Note: do not treat K if laboratory reports specimen "hemolyzed" -send a new specimen for testing. b. Assure all K removed from current infusions. c. Repeat serum K q 1 hour d. Give IV:
1. 50cc of 50% dextrose (D50) (one pre-filled syringe)
Rx Guideline -Acid-Base Treatment
Introduction
During donor care monitoring and treating the arterial pH becomes the primary acid/base goal. Because there are few primary effects of hypocarbia or hypercarbia, the PaCO 2 will be adjusted to normalize the arterial pH (pH 7.35 -7.45). Modifications of the mechanical ventilator to alter the PCO 2 , and hence pH, are reviewed in the Rx Guideline -Mechanical Ventilation.
I. Assessment -Because hospitals may report either the Base Excess (BE) or Base Deficit (BD) with ABG results, both are included here.
A. Acidosis -Review the arterial blood gas (ABG) measurement obtained prior to manipulation of the mechanical ventilator recommended in the Rx Guideline -Mechanical Ventilation. Assess the BE or BD provided as part of the ABG results. If the BE is more negative (-) than -6 or the BD is more positive (+) than +6, metabolic acidosis is likely present. B. Alkalosis -Review the ABG prior to adjustment of the mechanical ventilator as above. If the BE is more positive (+) than +6 or BD is more negative (-) than -6, metabolic alkalosis is likely present, although very unusual during donor care. 
II. Treatment
